本指南由時任ESVS大會副主席Marianne De Maeseneer女士，全權授權予紀永威教授(中國臺灣)將歐洲慢性靜脈疾病診療指南，為海峽兩岸及港澳地區以及其他使用中文服務于患者的醫生同業提供無償服務。紀教授邀請陳忠教授、符偉國教授、郭偉教授三位教授共同編譯，連續連載，為廣大醫療專業人士提供重要的資源，幫助他們根據最新的臨床證據為CVD患者制定個性化的治療方案。   

☆本指南未涵蓋的領域☆

    由于可能導致冗余，ESVS 指南的一般規則是避免納入在多個指南中覆蓋的患者群體。因此，這些指南僅簡單提及淺靜脈血栓形成（superficial vein thrombosis，SVT）患者，而不包括深靜脈血栓形成（deep vein thrombosis，DVT）患者，即使SVT和DVT都可能作為 CVD患者的急性并發癥發生。由于這些急性情況需要不同的處理，讀者可參考ESVS 2021年靜脈血栓管理臨床實踐指南[2]。該指南還決定排除先天性靜脈畸形（將成為未來ESVS血管畸形指南的一部分）和靜脈腫瘤。

☆總結☆

    為了進一步強調指南支持性，特別邀請了歐洲和非歐洲的審查人員審閱該指南，以便服務于歐洲以外的醫生。這也是所有ESVS指南都可以從出版商網站和ESVS網站www.esvs.org免費下載的原因。此外，我們還提供了ESVS臨床指南應用程序，方便于日常工作使用。

☆Areas not covered by these guidelines☆

The general rule for ESVS guidelines is to avoid covering groups redundancy. Therefore, patients with superficial vein throm bosis (SVT) are mentioned only briefly and patients with deep vein thrombosis (DVT) are not covered in these guidelines, even if both SVT and DVT may occur as acute complications in patients with CVD. As these acute conditions require different management, the reader is referred to the ESVS 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis.2 It was also decided to leave out congenital venous malformations, which will be part of future ESVS guidelines on vascular malformations, as well as venous tumours.

☆ summary ☆

To further underline the supportive character of the guidelines, both European and non-European reviewers were invited to review the document, so that the document also can serve practitioners treating patients outside Europe. This is also the rationale behind the decision that all ESVS guidelines are free to download from the publisher’s website and the ESVS website www.esvs.org. In  addition, an ESVS clinical guidelines App is available, where the guidelines can be found in easily readable form for use in everyday practice.

☆專家介紹☆

梅塞尼爾教授

Marianne De Maeseneer MD, PhD

醫學博士/教授